Plasma Therapy and Transfusion Technology最新文献_第4页

The fate of cells of the immune system during blood storage and after transfusion 在血液储存期间和输血后免疫系统细胞的命运

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90006-X

Neil Blumberg MD

引用次数: 1

Heredopathia atactica polyneuritiformis (Refsum's disease) treated by diet and plasma exchange—follow-up study of one case over eight years 饮食与血浆交换治疗无动性多神经炎(Refsum's disease) 1例8年随访研究

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90037-X

D. Kamanabroo , H. Feldmann , H. Schriever , J. Van de Loo

引用次数: 1

Plasma exchange in the successful treatment of severe drug-induced toxic epidermal necrolysis (Lyell's disease) 血浆置换成功治疗严重药物性中毒性表皮坏死松解症(莱尔氏病)

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90041-1

D. Kamanabroo , W. Schmitz-Landgraf

引用次数: 1

Long-term application of three types of sorbents for LDL-apheresis 三种吸附剂在ldl分离中的长期应用

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90031-9

V. Kukharchuk, G. Konovalov, A. Vedernikov, I. Adamova, G. Benevolenskaya, V. Sinitsyn, I. Trakht, S. Pokrovsky

引用次数: 6

Perspectives of the symposium “Hemapheresis”, held in Dordrecht, The Netherlands, 10 September 1987 1987年9月10日在荷兰多德雷赫特举行的“血液学”专题讨论会的观点

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90019-8

L. Kater MD, PhD , J.Ph. Sybesma MD, PhD

{"title":"Perspectives of the symposium “Hemapheresis”, held in Dordrecht, The Netherlands, 10 September 1987","authors":"L. Kater MD, PhD , J.Ph. Sybesma MD, PhD","doi":"10.1016/0278-6222(88)90019-8","DOIUrl":"10.1016/0278-6222(88)90019-8","url":null,"abstract":"<div>The symposium “Haemapheresis” was held on 10 September 1987 in Dordrecht, The Netherlands, celebrating the 10th anniversary of the Blood Bank “Zuid-West Nederland”. Various aspects of donor and of therapeutic apheresis were discussed.A main issue is the assessment of indications for the therapeutic use of haemapheresis. Haemapheresis has been attempted as a treatment modality in more than 150 diseases. In a report of the Health Council of the Netherlands “Therapeutic Haemapheresis” issued in 1986, categories have been described for indications (A-F): <ul><li>&#x02022;• Category A pertained to an established indication fulfilling all criteria listed;</li><li>&#x02022;• Category B holds for an acceptable indication, which is fully proved;</li><li>&#x02022;• Category C is labelled, to be “an emergency indication”. This means that, although proof of efficacy is lacking, there are certain conditions in which haemapheresis cannot be withheld from a patient;</li><li>&#x02022;• Category D comprises diseases, in which the indication is not yet established and more randomised clinical trials are needed;</li><li>&#x02022;• Category E refers to more experimental indications for haemapheresis;</li><li>&#x02022;• Category F means that there is no indication for haemapheresis. Reports on therapeutic haemapheresis have to be considered within the framework of these guidelines.</li></ul>In the presentations on donor apheresis an update was given on new developments in technology, including ways to obtain cell components and the side-effects and complications of the procedures.</div>","PeriodicalId":101030,"journal":{"name":"Plasma Therapy and Transfusion Technology","volume":"9 4","pages":"Pages 377-384"},"PeriodicalIF":0.0,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0278-6222(88)90019-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84749734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Continuous-flow apheresis of microfilariae in Loa loa infestations 微丝虫在罗阿螨侵染中的连续流动分离

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90040-X

Peter Kern, Peter Wind, Manfred Dietrich

{"title":"Continuous-flow apheresis of microfilariae in Loa loa infestations","authors":"Peter Kern, Peter Wind, Manfred Dietrich","doi":"10.1016/0278-6222(88)90040-X","DOIUrl":"10.1016/0278-6222(88)90040-X","url":null,"abstract":"<div>Loiasis is endemic in the tropical rain forest of Central and some parts of West Africa and is transmitted by the insect vector Chrysops silacea and Chrysops dimidiata. Loa loa infestation causes local inflammation due to migrating adult worms in the subcutis (Calabar swelling) and in the conjunctivae (eye worm). The diagnosis is made by the demonstration of circulating blood microfilariae, the larvae of the adult worms. Since the density of the microfilariae is very low, they can only be identified by concentration methods, such as hemofiltration. During treatment with the specific antiparasitic drug (diethylcarbamazine, DEC), side effects such as allergic reactions due to the rapid disruption of circulating microfilariae may occur. Those symptoms are aggravated in patients with a high number of larvae, leading to meningo-encephalomyelitis or even death.1Since microfilariae accumulate in the buffy coat during leukocytapheresis,2 it was thought that this technique might be a suitable tool to reduce the parasite load and to bypass the side effects of specific drug treatment. Muylle et al. achieved apheresis of microfilariae in two patients with Loa loa infestation by using a Haemonetics, M-300 blood processor.3 The authors studied two patients with an excessive microfilarial count in the peripheral blood of up to 9/μL and achieved a high enrichment by discontinuous-flow centrifugation. A similar observation was reported by Saeed et al. later on. 4 We have studied two patients with loiasis and report the results of microfilarial apheresis using a continuous-flow IBM/Cobe cell separator.</div>","PeriodicalId":101030,"journal":{"name":"Plasma Therapy and Transfusion Technology","volume":"9 1","pages":"Pages 95-98"},"PeriodicalIF":0.0,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0278-6222(88)90040-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86601378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Transmission of viral infection by preparations of intravenous immunoglobulin 静脉注射免疫球蛋白制剂对病毒感染的传播

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90051-4

J. Bussel, C. Cunningham-Rundles, C. Feldman, B. Horowitz

引用次数: 11

Case report: HIV infection after plasma exchanges for bullous pemphigoid 一例报告:大疱性类天疱疮血浆置换后HIV感染

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90014-9

B. Guillot, J. Reynes, D. Donadio

引用次数: 0

Plasma exchange therapy in ophthalmology 血浆交换疗法在眼科中的应用

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90033-2

R. Brunner, H. Borberg

引用次数: 1

New aspects of immunoglobulin treatment for idiopathic thrombocytopenic purpura 免疫球蛋白治疗特发性血小板减少性紫癜的新进展

Plasma Therapy and Transfusion Technology Pub Date : 1988-01-01 Epub Date: 2004-04-15 DOI: 10.1016/0278-6222(88)90038-1

U.E. Nydegger

引用次数: 0